E.Coli O157:H7 outbreak associated with fresh cheese curds

Article

American Medical Association

A recent report in the October 13 issue of the Morbidity and Mortality Weekly Report (MMWR) indicates that a June 1998 outbreak was due to fresh cheese curds in a dairy plant.

On June 15, 1998, the Division of Public Health, Wisconsin Department of Health and Family Services, was notified of eight laboratory-confirmed and four suspected Eschericia coli O157:57 infections among west-central Wisconsin residents who became ill during June 8-12.

As a result of the outbreak investigation, the eating of fresh cheese curds produced from one dairy plant was implicated.

The investigation further showed that the dairy plant produced unpasteurized (raw milk) cheddar cheese daisies. Certain raw milk cheese products can produced and legally sold as long as the cheese is held at <35 F (.1.7 C) for at least 60 days before it is sold. However, cheese curds are sold fresh (held <60 days); therefore curds must be made with pasteurized milk. It turns out that at least one 1,500-lbs vat of raw milk cheddar cheese was used inadvertently to make fresh curds, which were incorrectly labeled "pasteurized" cheddar cheese curds, and distributed and sold in six Wisconsin counties.

The accompanying editorial (in Morbidity and Mortality Weekly) emphasizes that raw milk consumption has been associated with campylobacteriosis, salmonellosis, E. coli O157:57, yersiniosis, listeriosis, tuberculosis, brucellosis, cryptosporidiosis, and staphylococcal enteroxin poisoning. Additionally, the editorial says that this outbreak investigation illustrates the hazards of using raw milk to produce commercial products that may lead to mislabeling or contaminating pasteurized product by equipment or ingredients. This practice can result in pasteurized products contaminated by equipment or ingredients and in product mislabeling.

Recent Videos
Lindsay K. Weir, MPH, CIC, Lead Infection Preventionist/Infection Preventionist III
•	Rebecca (Bartles) Crapanzano-Sigafoos, DrPH, MPH, CIC, FAPIC (corresponding author), executive director of APIC’s Center for Research, Practice, and Innovation, and lead author of the study.
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Related Content